Clinical concerns in the ultrasound exposure of the developing central nervous system

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Neurosonography is used as a primary imaging modality worldwide for visualization of the developing brain and spinal cord in fetuses, infants and children. During the entire process of brain development, there is rapid cell turnover, a condition that is favorable for genetic mutations once external stimuli are applied. No clinical studies in humans have been performed specifically to discuss the long-term impact of postnatal ultrasound exposure of the central nervous system. Currently published studies concerning the prenatal and postnatal use of Doppler or of ultrasound contrast agent use and the developing central nervous system are insufficient to draw meaningful conclusions regarding safety. By instituting a standardized examination and following appropriate patient handling guidelines, the risk of an adverse outcome associated with neurosonography is minimized. This paper recommends adoption of the ALARA principle and offers suggestions as to how to minimize the risk of adverse effects in neurosonography.

Original languageEnglish (US)
Pages (from-to)889-892
Number of pages4
JournalUltrasound in Medicine and Biology
Volume27
Issue number7
DOIs
StatePublished - Aug 14 2001

Fingerprint

central nervous system
brain
Central Nervous System
Moving and Lifting Patients
Doppler Ultrasonography
spinal cord
fetuses
Brain
mutations
stimuli
Contrast Media
suggestion
safety
Spinal Cord
Fetus
examination
Guidelines
Safety
Mutation
cells

Keywords

  • Clinical concerns
  • Neurosonography
  • Ultrasound and the central nervous system
  • Ultrasound safety

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Clinical concerns in the ultrasound exposure of the developing central nervous system. / Barr, Lori.

In: Ultrasound in Medicine and Biology, Vol. 27, No. 7, 14.08.2001, p. 889-892.

Research output: Contribution to journalArticle

@article{e33d82fa1c014549a99c8fcae4d81feb,
title = "Clinical concerns in the ultrasound exposure of the developing central nervous system",
abstract = "Neurosonography is used as a primary imaging modality worldwide for visualization of the developing brain and spinal cord in fetuses, infants and children. During the entire process of brain development, there is rapid cell turnover, a condition that is favorable for genetic mutations once external stimuli are applied. No clinical studies in humans have been performed specifically to discuss the long-term impact of postnatal ultrasound exposure of the central nervous system. Currently published studies concerning the prenatal and postnatal use of Doppler or of ultrasound contrast agent use and the developing central nervous system are insufficient to draw meaningful conclusions regarding safety. By instituting a standardized examination and following appropriate patient handling guidelines, the risk of an adverse outcome associated with neurosonography is minimized. This paper recommends adoption of the ALARA principle and offers suggestions as to how to minimize the risk of adverse effects in neurosonography.",
keywords = "Clinical concerns, Neurosonography, Ultrasound and the central nervous system, Ultrasound safety",
author = "Lori Barr",
year = "2001",
month = "8",
day = "14",
doi = "10.1016/S0301-5629(01)00374-X",
language = "English (US)",
volume = "27",
pages = "889--892",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Clinical concerns in the ultrasound exposure of the developing central nervous system

AU - Barr, Lori

PY - 2001/8/14

Y1 - 2001/8/14

N2 - Neurosonography is used as a primary imaging modality worldwide for visualization of the developing brain and spinal cord in fetuses, infants and children. During the entire process of brain development, there is rapid cell turnover, a condition that is favorable for genetic mutations once external stimuli are applied. No clinical studies in humans have been performed specifically to discuss the long-term impact of postnatal ultrasound exposure of the central nervous system. Currently published studies concerning the prenatal and postnatal use of Doppler or of ultrasound contrast agent use and the developing central nervous system are insufficient to draw meaningful conclusions regarding safety. By instituting a standardized examination and following appropriate patient handling guidelines, the risk of an adverse outcome associated with neurosonography is minimized. This paper recommends adoption of the ALARA principle and offers suggestions as to how to minimize the risk of adverse effects in neurosonography.

AB - Neurosonography is used as a primary imaging modality worldwide for visualization of the developing brain and spinal cord in fetuses, infants and children. During the entire process of brain development, there is rapid cell turnover, a condition that is favorable for genetic mutations once external stimuli are applied. No clinical studies in humans have been performed specifically to discuss the long-term impact of postnatal ultrasound exposure of the central nervous system. Currently published studies concerning the prenatal and postnatal use of Doppler or of ultrasound contrast agent use and the developing central nervous system are insufficient to draw meaningful conclusions regarding safety. By instituting a standardized examination and following appropriate patient handling guidelines, the risk of an adverse outcome associated with neurosonography is minimized. This paper recommends adoption of the ALARA principle and offers suggestions as to how to minimize the risk of adverse effects in neurosonography.

KW - Clinical concerns

KW - Neurosonography

KW - Ultrasound and the central nervous system

KW - Ultrasound safety

UR - http://www.scopus.com/inward/record.url?scp=0034901619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034901619&partnerID=8YFLogxK

U2 - 10.1016/S0301-5629(01)00374-X

DO - 10.1016/S0301-5629(01)00374-X

M3 - Article

VL - 27

SP - 889

EP - 892

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 7

ER -